IAM
MDT icon

Impax Asset Management’s Medtronic MDT Stock Holding History

Impax Asset Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$1.37M Buy
16,040
+1,508
+10% +$126K 0.08% 141
2018
Q1 		$1.17M Buy
14,532
+1,908
+15% +$157K 0.07% 146
2017
Q4 		$1.02M Buy
12,624
+1,092
+9% +$87.5K 0.06% 141
2017
Q3 		$897K Buy
11,532
+700
+6% +$58.1K 0.05% 147
2017
Q2 		$961K Buy
10,832
+1,000
+10% +$84.3K 0.05% 143
2017
Q1 		$792K Buy
9,832
+600
+6% +$46.9K 0.04% 152
2016
Q4 		$658K Buy
9,232
+300
+3% +$23.6K 0.04% 151
2016
Q3 		$772K Buy
8,932
+600
+7% +$52.3K 0.04% 144
2016
Q2 		$723K Sell
8,332
-400
-5% -$32.3K 0.04% 155
2016
Q1 		$655K Buy
8,732
+1,632
+23% +$123K 0.04% 184
2015
Q4 		$546K Buy
+7,100
New +$534K 0.03% 171
2015
Q1 		– Sell
-3,994
Closed -$288K – 197
2014
Q4 		$288K Buy
3,994
+295
+8% +$20.5K 0.02% 183
2014
Q3 		$229K Buy
+3,699
New +$235K 0.01% 183

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Impax Asset Management's MDT Position: Q2 2018 in Review

Impax Asset Management increased its Medtronic (MDT) stake by 10% in Q2 2018, buying an estimated $126K and bringing the position to 16,040 shares worth $1.37M. The position accounts for 0.08% of the portfolio, ranked #141.

Impax Asset Management first reported a position in MDT in Q3 2014 and has held it in 13 quarters since. 1,409 funds tracked by Wall St. Rank hold MDT as of Q2 2018.

  • Impax Asset Management held 16,040 shares of Medtronic worth $1.37M as of Q2 2018.
  • Impax Asset Management bought 1,508 Medtronic shares in Q2 2018, an estimated $126K.
  • Medtronic made up 0.08% of Impax Asset Management's portfolio in Q2 2018, its #141 holding.
  • Impax Asset Management first reported a position in Medtronic in Q3 2014 and has held it in 13 quarters since.
  • 1,409 funds tracked by Wall St. Rank held Medtronic as of Q2 2018.

Based on Impax Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.